litlas
ログインアカウント作成

Walter Weder

1990–2025 年に発表

111
論文数
19,448
被引用数
78
h 指数
108
i10 指数

被引用数

Walter Weder の年別被引用数1926 年: 被引用 1 件1971 年: 被引用 3 件1976 年: 被引用 1 件1990 年: 被引用 2 件1992 年: 被引用 1 件1993 年: 被引用 2 件1994 年: 被引用 2 件1995 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 6 件1998 年: 被引用 18 件1999 年: 被引用 28 件2000 年: 被引用 27 件2001 年: 被引用 33 件2002 年: 被引用 38 件2003 年: 被引用 60 件2004 年: 被引用 76 件2005 年: 被引用 88 件2006 年: 被引用 76 件2007 年: 被引用 82 件2008 年: 被引用 98 件2009 年: 被引用 118 件2010 年: 被引用 88 件2011 年: 被引用 103 件2012 年: 被引用 105 件2013 年: 被引用 155 件2014 年: 被引用 148 件2015 年: 被引用 157 件2016 年: 被引用 172 件2017 年: 被引用 117 件2018 年: 被引用 116 件2019 年: 被引用 444 件2020 年: 被引用 468 件2021 年: 被引用 497 件2022 年: 被引用 381 件2023 年: 被引用 280 件2024 年: 被引用 490 件2025 年: 被引用 225 件2026 年: 被引用 3 件1927〜1970 年は被引用が無いため表示していません1972〜1975 年は被引用が無いため表示していません1977〜1989 年は被引用が無いため表示していません1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,633 件、この内訳の 22.8%中国: 引用元論文 745 件、この内訳の 10.4%イギリス: 引用元論文 448 件、この内訳の 6.2%ドイツ: 引用元論文 427 件、この内訳の 6%イタリア: 引用元論文 413 件、この内訳の 5.8%日本: 引用元論文 313 件、この内訳の 4.4%スイス: 引用元論文 312 件、この内訳の 4.3%フランス: 引用元論文 309 件、この内訳の 4.3%オランダ: 引用元論文 266 件、この内訳の 3.7%カナダ: 引用元論文 258 件、この内訳の 3.6%スペイン: 引用元論文 252 件、この内訳の 3.5%オーストラリア: 引用元論文 182 件、この内訳の 2.5%
0%22.8%その他 22.5%

機関

分野

  • Medicine82.1%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Immunology and Microbiology2.7%
  • Engineering1.1%
  • Neuroscience0.6%
  • Materials Science0.6%
  • その他1.4%

トピック

  • Lung Cancer Diagnosis and Treatment9%
  • Lung Cancer Treatments and Mutations7.3%
  • Lung Cancer Research Studies6.4%
  • Radiomics and Machine Learning in Medical Imaging4%
  • Cancer Immunotherapy and Biomarkers3.5%
  • Pleural and Pulmonary Diseases3.1%
  • その他66.7%

共著者

全論文

検索で開く
  1. Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

    著者: Jamie E. Chaft, Andreas Rimner, Walter Weder, Christopher G. Azzoli, Mark G. Kris, Tina Cascone - Nature Reviews Clinical Oncology 2021 被引用: 391

  2. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    著者: William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy J. Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Tae Kim, Fernando López‐Ríos, Shun Lü, Tetsuya Mitsudomi, André Moreira, Noriko Motoi, Andrew G. Nicholson, Ricardo Oliveira, Mauro Papotti, Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 被引用: 450

  3. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    著者: Martin Peifer, Lynnette Fernandez‐Cuesta, Martin L. Sos, Julie George, Danila Seidel, Lawryn H. Kasper, Dennis Plenker, Frauke Leenders, Ruping Sun, Thomas Zander, Roopika Menon, Mirjam Koker, Ilona Dahmen, Christian Müller, Vincenzo Di Cerbo, Hans‐Ulrich Schildhaus, Janine Altmüller, Ingelore Baessmann, Christian Becker, Bram De Wilde, Jo Vandesompele, Diana Böhm, Sascha Ansén, Franziska Gabler, Ines Wilkening, Stefanie Heynck, Johannes M. Heuckmann, Xin Lü, Scott L. Carter, Kristian Cibulskis, Shantanu Banerji, Gad Getz, Kwon-Sik Park, Daniel Rauh, Christian Grütter, Matthias Fischer, Laura Pasqualucci, Gavin Wright, Zoe Wainer, Prudence A. Russell, Iver Petersen, Yuan Chen, Erich Stoelben, Corinna Ludwig, Philipp A. Schnabel, Hans Hoffmann, Thomas Muley, Michael Brockmann, Walburga Engel-Riedel, Lucia Anna Muscarella, Vito Michele Fazio, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erik Thunnissen, Egbert F. Smit, Daniëlle A.M. Heideman, Peter J.F. Snijders, Federico Cappuzzo, Claudia Ligorio, Stefania Damiani, John K. Field, Steinar Solberg, Odd Terje Brustugun, Marius Lund‐Iversen, Jörg Sänger, Joachim H. Clement, Alex Soltermann, Holger Moch, Walter Weder, Benjamin Solomon, Jean‐Charles Soria, Pierre Validire, Benjamin Besse, Élisabeth Brambilla, Christian Brambilla, Sylvie Lantuéjoul, Philippe Lorimier, Peter M. Schneider, Michael Hallek, William Pao, Matthew Meyerson, Julien Sage, Jay Shendure, Robert C. Schneider, Reinhard Büttner, Jürgen Wolf, Peter Nürnberg, Sven Perner, Lukas C. Heukamp, Paul K. Brindle, Stefan A. Haas, Roman K. Thomas - Nature Genetics 2012 被引用: 1,418

  4. Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

    著者: Tina Cascone, Gozde Kar, Jonathan Spicer, Rosario García-Campelo, Walter Weder, Davey B. Daniel, David R. Spigel, Maen Hussein, Julien Mazières, Júlio Oliveira, Edwin Yau, Alexander I. Spira, Valsamo Anagnostou, Raymond Mager, Oday Hamid, Lin‐Yang Cheng, Ying Zheng, Jorge Blando, Tze Heng Tan, Michael Surace, Jaime Rodriguez‐Canales, Vancheswaran Gopalakrishnan, Bret R. Sellman, Italia Grenga, Yee Soo-Hoo, Rakesh Kumar, Lara McGrath, Patrick M. Forde - Cancer Discovery 2023 被引用: 117

  5. SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial

    著者: Sacha I. Rothschild, Alfred Zippelius, E.I. Eboulet, Spasenija Savic Prince, Daniel Betticher, Adrienne Bettini, Martin Früh, Markus Joerger, Didier Lardinois, Hans Gelpke, Laetitia Mauti, Christian Britschgi, Walter Weder, Solange Peters, Michael Mark, Richard Cathomas, Adrian F. Ochsenbein, Wolf-Dieter Janthur, Christine Waibel, Nicolas Mach, Patrizia Froesch, Martin Buess, Pierre Bohanes, Gilles Godar, Corinne Rusterholz, Michel González, Miklos Pless - Journal of Clinical Oncology 2021 被引用: 341

  6. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer

    著者: Paul De Leyn, Christophe Dooms, J. Kuzdzal, Didier Lardinois, Bernward Passlick, Ramón Rami–Porta, Akif Turna, Paul Van Schil, Federico Venuta, David Waller, Walter Weder, Marcin Zieliński - European Journal of Cardio-Thoracic Surgery 2014 被引用: 831

  7. Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for EGFR -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA

    著者: Masahiro Tsuboi, Walter Weder, Carles Escriu, Collin M. Blakely, Jianxing He, Sanja Đačić, Yasushi Yatabe, Lingmin Zeng, Andrew Walding, Jamie E. Chaft - Future Oncology 2021 被引用: 189

  8. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

    著者: Julie George, Vonn Walter, Martin Peifer, Ludmil B. Alexandrov, Danila Seidel, Frauke Leenders, Lukas Maas, Christian Müller, Ilona Dahmen, Tiffany M. Delhomme, Maude Ardin, Noémie Leblay, Graham Byrnes, Ruping Sun, Aurélien de Reyniès, Anne McLeer‐Florin, Graziella Bosco, Florian Malchers, Roopika Menon, Janine Altmüller, Christian Becker, Peter Nürnberg, Viktor Achter, Ulrich Lang, Peter M. Schneider, Magdalena Bogus, Matthew G. Soloway, Matthew D. Wilkerson, Yupeng Cun, James McKay, Denis Moro‐Sibilot, Christian Brambilla, Sylvie Lantuéjoul, Nicolas Lemaître, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund‐Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, D. Neil Hayes, Élisabeth Brambilla, Lynnette Fernandez‐Cuesta, Roman K. Thomas - Nature Communications 2018 被引用: 373

  9. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

    著者: Stefanie Hiltbrunner, Christian Britschgi, Petra Schuberth, Lorenz Bankel, Thi Dan Linh Nguyen‐Kim, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Hans Bachmann, Annett Tabor, Petra Schröder, Alexander Knuth, Christian Münz, Rolf A. Stahel, Onur Boyman, Christoph Renner, Ulf Petrausch, Alessandra Curioni‐Fontecedro - Annals of Oncology 2020 被引用: 88

  10. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

    著者: Miklos Pless, Roger Stupp, Hans-Beat Ris, Rolf A. Stahel, Walter Weder, Sandra Thierstein, Marie-Aline Gérard, Alexandros Xyrafas, Martin Früh, Richard Cathomas, Alfred Zippelius, Arnaud Roth, Milorad Bijelović, Adrian F. Ochsenbein, Urs R. Meier, Christoph Mamot, Daniel Rauch, Oliver Gautschi, Daniel Betticher, René-Olivier Mirimanoff, Solange Peters - The Lancet 2015 被引用: 390

  11. A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells

    著者: A. Curioni, Christian Britschgi, Stefanie Hiltbrunner, Lorenz Bankel, P. Gulati, Walter Weder, Isabelle Opitz, Olivia Lauk, Claudio Caviezel, Alexander Knuth, Christian Münz, C. Renner, Rolf A. Stahel, Ulf Petrausch - Annals of Oncology 2019 被引用: 53

  12. Influence of inter-observer delineation variability on radiomics stability in different tumor sites

    著者: Matea Pavic, Marta Bogowicz, Xaver Würms, S. Glatz, Tobias Finazzi, Oliver Riesterer, Johannes Roesch, Leonie Rudofsky, Martina Friess, Patrick Veit‐Haibach, Martin W. Huellner, Isabelle Opitz, Walter Weder, Thomas Frauenfelder, Matthias Gückenberger, Stephanie Tanadini‐Lang - Acta Oncologica 2018 被引用: 200

  13. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    著者: Wilfried Eberhardt, Dirk De Ruysscher, Walter Weder, C. Le Péchoux, Paul De Leyn, H. Hoffmann, Virginie Westeel, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2015 被引用: 398

  14. Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)

    著者: Ulf Petrausch, Petra Schuberth, Christian Hagedorn, Alex Soltermann, Sandra Tomaszek, Rolf A. Stahel, Walter Weder, Christoph Renner - BMC Cancer 2012 被引用: 90

  15. Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database

    著者: Valerie W. Rusch, Dorothy J. Giroux, Catherine Kennedy, Enrico Ruffini, Ayten Cangır, David C. Rice, Harvey I. Pass, Hisao Asamura, David Waller, John Edwards, Walter Weder, Hans Hoffmann, Jan P. van Meerbeeck - Journal of Thoracic Oncology 2012 被引用: 401

  16. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

    著者: Daniel Betticher, Shu‐Fang Hsu Schmitz, Martin Tötsch, Eva Støttrup Hansen, Christine Joss, Christian von Briel, Ralph A. Schmid, Miklos Pless, James Habicht, Arnaud Roth, Anastase Spiliopoulos, Rolf A. Stahel, Walter Weder, Roger Stupp, F Egli, Markus Furrer, Hanspeter Honegger, Martin Wernli, Thomas Cerny, Hans-Beat Ris - Journal of Clinical Oncology 2003 被引用: 455

  17. Perioperative course and quality of life in a prospective randomized multicenter phase III trial, comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th edition of TNM staging system)

    著者: Georgios Stamatis, Gunda Leschber, Birte Schwarz, Diana Lütke Brintrup, Claudia Ose, Gerhard Weinreich, Bernward Passlick, E. Hecker, Christian Kügler, Hendrik Dienemann, Thomas Krbek, Stephan Eggeling, Rudolf Hatz, Michael Müller, Walter Weder, Clemens Aigner, Karl‐Heinz Jöckel - Lung Cancer 2019 被引用: 77

  18. Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer

    著者: Alex Soltermann, Verena Tischler, Stefanie Arbogast, Julia Braun, Nicole Probst‐Hensch, Walter Weder, Holger Moch, Glen Kristiansen - Clinical Cancer Research 2008 被引用: 271

  19. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

    著者: Benjamin Besse, A. Adjei, P. Baas, Peter Meldgaard, M. Nicolson, Luis Paz‐Ares, Martin Reck, Egbert F. Smit, Konstantinos Syrigos, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Rolf A. Stahel, Enriqueta Felip, Solange Peters, Keith M. Kerr, Benjamin Besse, Johan Vansteenkiste, Wilfried Eberhardt, Martin J. Edelman, Tony Mok, Kenneth J. O’Byrne, Silvia Novello, Lukas Bubendorf, Antonio Marchetti, Paul Baas, Martin Reck, Konstantinos Syrigos, Luis Paz‐Ares, Egbert F. Smit, Peter Meldgaard, Alex A. Adjei, M. Nicolson, Lucio Crinò, Paul Van Schil, Suresh Senan, Corinne Faivre‐Finn, Gaetano Rocco, Giulia Veronesi, Jean-Yves Douillard, Eric Lim, Christophe Dooms, Walter Weder, Dirk De Ruysscher, C. Le Péchoux, Paul De Leyn, Virginie Westeel - Annals of Oncology 2014 被引用: 247

  20. Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma

    著者: Kathrin Oehl, Bart Vrugt, Ulrich Wagner, Michaela B. Kirschner, Mayura Meerang, Walter Weder, Emanuela Felley‐Bosco, Bernd Wollscheid, Katrin Bankov, Melanie Demes, Isabelle Opitz, Peter J. Wild - Clinical Cancer Research 2021 被引用: 43

  21. Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

    著者: David König, Sämi Schär, Diem Vuong, Matthias Gückenberger, Katarzyna Furrer, Isabelle Opitz, Walter Weder, Sacha I. Rothschild, Adrian F. Ochsenbein, Alfred Zippelius, Alfredo Addeo, Michael Mark, E.I. Eboulet, Stefanie Hayoz, Sandra Thierstein, Daniel Betticher, H.-B. Ris, Roger Stupp, Alessandra Curioni‐Fontecedro, Solange Peters, Miklos Pless, Martin Früh - ESMO Open 2022 被引用: 24

  22. Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review

    著者: Collin M. Blakely, Walter Weder, Lukas Bubendorf, Jianxing He, Margarita Majem, Yu Shyr, Jamie E. Chaft - Lung Cancer 2023 被引用: 22

  23. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: Lucio Crinò, Walter Weder, Jan P. van Meerbeeck, Enriqueta Felip - Annals of Oncology 2010 被引用: 539

  24. Extracorporeal Photopheresis After Lung Transplantation: A 10-Year Single-Center Experience

    著者: Christian Benden, Rudolf Speich, Günther F.L. Hofbauer, Sarosh R. Irani, Christine Eich-Wanger, Erich W. Russi, Walter Weder, Annette Boehler - Transplantation 2008 被引用: 161